Patents by Inventor Hongrui YU

Hongrui YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210171536
    Abstract: The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 10, 2021
    Applicant: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting LI, Deqiang WANG, Wei CHANG, Hongrui YU, Xiaoming ZOU
  • Patent number: 10954246
    Abstract: A crystalline form of Mod. I of Formula I: And, a process for the preparation of the crystalline form and a pharmaceutical use of the crystalline form.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: March 23, 2021
    Assignee: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting Li, Deqiang Wang, Wei Chang, Hongrui Yu, Xiaoming Zou
  • Publication number: 20200071336
    Abstract: The present application relates to a crystalline form of 4-(4-chloroanilino)-7-(2-methylaminocarbonyl-4-oxymethyl)pyridylfuro[2,3-d]pyridazine mesylate (EOC315) that contains crystalline form Mod. I. The present application also relates to a process for the preparation of the crystalline form and the pharmaceutical use of the crystalline form.
    Type: Application
    Filed: October 11, 2019
    Publication date: March 5, 2020
    Applicant: Taizhou EOC Pharma Co., Ltd.
    Inventors: Heting LI, Deqiang WANG, Wei CHANG, Hongrui YU, Xiaoming ZOU